These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 34074778)

  • 1. Structures suggest an approach for converting weak self-peptide tumor antigens into superagonists for CD8 T cells in cancer.
    Wei P; Jordan KR; Buhrman JD; Lei J; Deng H; Marrack P; Dai S; Kappler JW; Slansky JE; Yin L
    Proc Natl Acad Sci U S A; 2021 Jun; 118(23):. PubMed ID: 34074778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MHC-Optimized Peptide Scaffold for Improved Antigen Presentation and Anti-Tumor Response.
    Tagliamonte M; Mauriello A; Cavalluzzo B; Ragone C; Manolio C; Luciano A; Barbieri A; Palma G; Scognamiglio G; Di Mauro A; Di Bonito M; Tornesello ML; Buonaguro FM; Vitagliano L; Caporale A; Ruvo M; Buonaguro L
    Front Immunol; 2021; 12():769799. PubMed ID: 34745146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-associated antigen-based personalized dendritic cell vaccine in solid tumor patients.
    Wang QT; Nie Y; Sun SN; Lin T; Han RJ; Jiang J; Li Z; Li JQ; Xiao YP; Fan YY; Yuan XH; Zhang H; Zhao BB; Zeng M; Li SY; Liao HX; Zhang J; He YW
    Cancer Immunol Immunother; 2020 Jul; 69(7):1375-1387. PubMed ID: 32078016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide-based vaccination and induction of CD8+ T-cell responses against tumor antigens in breast cancer.
    Harao M; Mittendorf EA; Radvanyi LG
    BioDrugs; 2015 Feb; 29(1):15-30. PubMed ID: 25523015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell Receptors Engineered
    Sharma P; Harris DT; Stone JD; Kranz DM
    Cancer Immunol Res; 2019 Dec; 7(12):2025-2035. PubMed ID: 31548259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relating TCR-peptide-MHC affinity to immunogenicity for the design of tumor vaccines.
    McMahan RH; McWilliams JA; Jordan KR; Dow SW; Wilson DB; Slansky JE
    J Clin Invest; 2006 Sep; 116(9):2543-51. PubMed ID: 16932807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice.
    Obenaus M; Leitão C; Leisegang M; Chen X; Gavvovidis I; van der Bruggen P; Uckert W; Schendel DJ; Blankenstein T
    Nat Biotechnol; 2015 Apr; 33(4):402-7. PubMed ID: 25774714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TCR hypervariable regions expressed by T cells that respond to effective tumor vaccines.
    Jordan KR; Buhrman JD; Sprague J; Moore BL; Gao D; Kappler JW; Slansky JE
    Cancer Immunol Immunother; 2012 Oct; 61(10):1627-38. PubMed ID: 22350070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leveraging TCR Affinity in Adoptive Immunotherapy against Shared Tumor/Self-Antigens.
    Miller AM; Bahmanof M; Zehn D; Cohen EEW; Schoenberger SP
    Cancer Immunol Res; 2019 Jan; 7(1):40-49. PubMed ID: 30482746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide vaccines prevent tumor growth by activating T cells that respond to native tumor antigens.
    Jordan KR; McMahan RH; Kemmler CB; Kappler JW; Slansky JE
    Proc Natl Acad Sci U S A; 2010 Mar; 107(10):4652-7. PubMed ID: 20133772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell receptor binding affinity governs the functional profile of cancer-specific CD8+ T cells.
    Tan MP; Gerry AB; Brewer JE; Melchiori L; Bridgeman JS; Bennett AD; Pumphrey NJ; Jakobsen BK; Price DA; Ladell K; Sewell AK
    Clin Exp Immunol; 2015 May; 180(2):255-70. PubMed ID: 25496365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of affinity ranged antigen-expressing tumor cell lines.
    Martinez-Usatorre A; Romero P
    Methods Enzymol; 2020; 632():503-519. PubMed ID: 32000912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of agonistic altered peptides for the robust induction of CTL directed towards H-2Db in complex with the melanoma-associated epitope gp100.
    van Stipdonk MJ; Badia-Martinez D; Sluijter M; Offringa R; van Hall T; Achour A
    Cancer Res; 2009 Oct; 69(19):7784-92. PubMed ID: 19789338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining the antigen-specific T-cell response to vaccination and poly(I:C)/TLR3 signaling: evidence of enhanced primary and memory CD8 T-cell responses and antitumor immunity.
    Salem ML; Kadima AN; Cole DJ; Gillanders WE
    J Immunother; 2005; 28(3):220-8. PubMed ID: 15838378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of vaccine-induced effector CD8 T cell responses directed against self- and non-self-tumor antigens: implications for cancer immunotherapy.
    Pedersen SR; Sørensen MR; Buus S; Christensen JP; Thomsen AR
    J Immunol; 2013 Oct; 191(7):3955-67. PubMed ID: 24018273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clonotypic T cell receptor is a source of tumor-associated antigens in cutaneous T cell lymphoma.
    Berger CL; Longley J; Hanlon D; Girardi M; Edelson R
    Ann N Y Acad Sci; 2001 Sep; 941():106-22. PubMed ID: 11594564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic TCR-MHC (self)-interactions limit the functional potential of TCR affinity-increased CD8 T lymphocytes.
    Duong MN; Erdes E; Hebeisen M; Rufer N
    J Immunother Cancer; 2019 Nov; 7(1):284. PubMed ID: 31690351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TAP-independent self-peptides enhance T cell recognition of immune-escaped tumors.
    Doorduijn EM; Sluijter M; Querido BJ; Oliveira CC; Achour A; Ossendorp F; van der Burg SH; van Hall T
    J Clin Invest; 2016 Feb; 126(2):784-94. PubMed ID: 26784543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Affinity of thymic self-peptides for the TCR determines the selection of CD8(+) T lymphocytes in the thymus.
    Ober BT; Hu Q; Opferman JT; Hagevik S; Chiu N; Wang CR; Ashton-Rickardt PG
    Int Immunol; 2000 Sep; 12(9):1353-63. PubMed ID: 10967031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative TCR:pMHC Dissociation Rate Assessment by NTAmers Reveals Antimelanoma T Cell Repertoires Enriched for High Functional Competence.
    Gannon PO; Wieckowski S; Baumgaertner P; Hebeisen M; Allard M; Speiser DE; Rufer N
    J Immunol; 2015 Jul; 195(1):356-66. PubMed ID: 26002978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.